Showing results (1-10 of 216) with videos related to
Sort By:
Pageof 22
Nephrologie & Therapeutique|February 16, 2013
[Renal toxicity of anti-VEGF (corrected) targeted therapies]Cécile Vigneau, Nathalie Rioux-LeclercqAnnales De Pathologie|December 11, 2008
[Renal cell carcinoma and prognostic factors]Julien Edeline, Nathalie Rioux-LeclercqAnnales De Pathologie|December 17, 2011
[The pathologist's role in the neoadjuvant strategy of renal-cell carcinoma]Xavier Leroy, Julien Edeline, Nathalie Rioux-LeclercqProgres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|January 25, 2006
[Molecular pathways of tumour angiogenesis and new targeted therapeutic approaches in renal cancer]Patricia Fergelot, Nathalie Rioux-Leclercq, Jean-Jacques PatardAnnals of Diagnostic Pathology|February 22, 2016
Clear cell papillary renal cell carcinoma, renal angiomyoadenomatous tumor, and renal cell carcinoma with leiomyomatous stroma relationship of 3 types of renal tumors: a reviewOndrej Hes, Eva Maria Compérat, Nathalie Rioux-LeclercqEuropean Urology|February 17, 2006
Understanding the importance of smart drugs in renal cell carcinomaJean-Jacques Patard, Nathalie Rioux-Leclercq, Patricia FergelotAnnales De Pathologie|May 10, 2024
[2022 WHO classification of renal cell carcinomas: Focus on papillary renal cell carcinoma]Sarah Bellal, Solène-Florence Kammerer-Jacquet, Nathalie Rioux-Leclercq, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 30, 2018
Non-Clear Cell Renal Cell Carcinomas: From Shadow to LightLaurence Albiges, Ronan Flippot, Nathalie Rioux-Leclercq, et al.Annales De Pathologie|February 23, 2023
[FH (Fumarate Hydratase)-deficient renal cell carcinoma: A case report]Pierre Allaume, Solène-Florence Kammerer-Jacquet, Stephanos Papadopoulos, et al.Annales De Pathologie|September 22, 2018
[Renal amyloidosis revealing a cryopyrin associated periodic syndrome]Gwladys Robinet, Eric Renaudineau, Claire Lamaison, et al.Pageof 22